Adaptations of maternal lipid metabolism during pregnancy are directed toward both the needs of the fetus for lipid substrates and maternal requirements for lipid stores serving as energy reserves for lactation. The mechanisms are poorly understood, but must be elucidated before new dietary recommendations can be made about dietary supplementation with long-chain polyunsaturated fatty acids (LC-PUFA). Problems of high priority for research are: (1) Fetal requirements for speci®c fatty acids, including essential fatty acids (EFA) and longchain polyunsaturated fatty acids (LC-PUFA); (2) The mechanisms for transfer of fatty acids across the placenta; (3) The role of very low density lipoproteins (VLDL) in transfer of EFA and LC-PUFA from the maternal liver to the placenta; (4) Adjustments of fatty acid metabolism in the maternal liver during pregnancy; and (5) The effect of dietary LC-PUFA on maternal fatty acid metabolism during pregnancy.
Introduction
In considering adaptations of maternal lipid metabolism to pregnancy both the needs of the fetus and the possible future maternal requirements for lipid stores during lactation should be considered. There is evidence for three general types of maternal adaptation in lipid metabolism during pregnancy:
1. During early pregnancy maternal adipose stores are increased (Institute of Medicine, 1991) . The physiological mechanisms involved in the accretion of increased adipose stores during the ®rst two trimesters of pregnancy are not clear although the utility of these stores for fetal and infant needs during late pregnancy and lactation is obvious. 2. An increase in intestinal absorption of nutrients accompanies the increased nutrient requirement (Hammond, 1997) . Whether increased intestinal absorption of lipid is a major factor in humans, where the nutrient demands of the fetus and of lactation are relatively small compared to other species (Prentice & Whitehead, 1987) , is not currently known. 3. Finally, we are just becoming aware of the importance of the¯ux of fatty acids, particularly essential fatty acids (EFA) and long-chain polyunsaturated fatty acids (LC-PUFA) from the mother to the fetus. Although glucose is the primary nutrient in the fetus, there is a large accretion of triacylglycerol as adipose tissue during the last trimester (Hay, 1995) . In addition long-chain polyunsaturated fatty acids, particularly arachidonate (AA,20:4n-6) and docosahexaenoic acid (DHA, are needed for membrane formation in all organs but particularly in the brain (Martinez, 1992) . Arachidonate is also an important precursor for lipid signaling molecules. Since LC-PUFA are synthesized in insuf®cient quantity by the fetus, and the placenta apparently does not possess the D5 and D6 desaturase activities to convert essential fatty acids to LC-PUFA (reviewed in Crawford, 1993; Campbell et al, 1996) , mechanisms for the preferential synthesis and transfer of these fatty acids to the fetus and placenta must be in place. Since these mechanisms are at the core of the most important questions concerning lipid metabolism in pregnancy, the focus of this discussion will be the problem of providing LC-PUFA to the fetus. A working hypothesis for lipid transfer to the fetus will be presented, evidence for adaptation of maternal metabolism will be discussed and a question concerning dietary supplementation with LC-PUFA will be raised.
A working hypothesis for transfer of essential fatty acids and LC-PUFA to the fetus Figure 1 shows some of the major lipid¯uxes between the motherandthefetus.This®gureillustratesthefollowingpoints:
The human fetus has a large requirement for lipid substrate in the form of fatty acids both for adipose tissue accretion and for membrane synthesis in the brain. Several mechanisms that potentially result in the preferential transfer of essential fatty acids and LC-PUFA to the fetus are present in the placenta. Maternal lipids arrive at the placenta in the form of both triacylglycerides, carried in chylomicrons and very low density lipoproteins (VLDL), and as free fatty acids. The proportion of lipid arriving as chylomicrons and as free fatty acids, derived largely from lipolysis of adipose tissue stores, depends on whether the mother is in the fed or fasting state. LC-PUFA are likely to derive from the liver. Hepatocytes possess the elongases and desaturases necessary to produce these molecules from EFA and the means to export them from the cell, for example VLDL formation.
VLDL are likely to be the major means by which maternally derived LC-PUFA are transferred to the placenta.
Some of these points will be elaborated here.
Placental accretion and transfer of fatty acids There are three possible mechanisms for transfer of fatty acids across the placenta, all of which are potentially selective for essential fatty acids and LC-PUFA. The ®rst is the presence of a plasma membrane fatty acid binding protein (FABP PM in Figure 1 ). FABP PM was identi®ed in human and sheep placenta by Campbell et al (1996) and the order of preference for the four fatty acids studied was arachidonic ) linoleic ) a-linolenic b b b b b oleic acid. Trans fatty acids inhibited the binding ef®ciently. An antiserum to FABP PM inhibited binding of the unsaturated fatty acids more than oleic acid. All these data provide evidence supporting the idea of preferential fatty acid binding in the placenta. Although the mechanism is not clear, FABP PM are currently considered to act as fatty acid transporters that shuttle fatty acids from the interstitial¯uid to the intracellular compartment. The idea that a fatty acid transporter with a preference for essential fatty acids and LC-PUFA is present in the placenta is supported by the work of Haggarty et al (1997) who studied the perfused placenta ®nding that the order of selectivity for transfer of fatty acids from the maternal vasculature to the fetal circulation was DHA b a-linolenic b linoleic b arachidonic. However, arachidonic acid was strongly accumulated (three-fold greater than DHA) in the placenta itself. Whether this localization of AA in the perfused isolated placenta is representative of the situation in vivo, is not clear.
However, the data indicate the presence of selective mechanisms for the transfer of LC-PUFA to the fetus.
Another player in the preferential transfer of LC-PUFA to the fetus may be a-fetoprotein. This protein is present in relatively high concentration (700 nM) in the fetal blood and the intervillous space but not the maternal blood (Benassayag et al, 1997) . Alpha-fetoprotein has been shown in a number of studies (reviewed in Benassayag et al, 1997) to bind PUFA more strongly than does albumin. The presence of this protein could account for the relatively high proportion of PUFA found not only in fetal plasma but also in the intervillous space.
Finally, a role for VLDL in the transfer of essential fatty acids and PUFA from the maternal liver to the placenta will be suggested below. The VLDL receptor (VLDL-R in Figure 1 ) has been shown to be present in high concentration in the term placenta localized to the syncytiotrophoblast and intermediate trophoblast cells (Wittmaack et al, 1995) . It is up-regulated at term compared to the ®rst trimester and appears to be subject to regulation by cAMP, insulin and clo®brate. The role of this receptor in the transfer of lipid to the placenta and fetus has yet to be elucidated.
In summary, a number of mechanisms are present in the human placenta that are potentially capable of selective transfer of essential fatty acids and LC-PUFA to the fetus. The mechanisms by which these operate, their relative importance and their possible regulation by maternal metabolic state remain to be elucidated. While it is likely that animal studies can shed some light on these problems, the very high needs of the human fetus for all types of fatty acids in the last trimester of pregnancy suggest that these mechanisms may be much more prominent in the human placenta than in the placentas of most common laboratory species. Fortunately human placenta is available for study. A ®nal point is that the needs of the placenta itself for fatty acids, particularly arachidonate, have not been well delineated and require much more study.
Lipid transfer from the maternal circulation to the placenta Lipids appear at the placenta in the form of triglycerides and phospholipids carried in lipoproteins, particularly chylomicra and VLDL, as well as in free fatty acids released from adipose tissue by lipolysis, a process that is much more active during the post-absorptive state. As far as is known, triglycerides are not transported across the placenta intact (Campbell et al, 1996) , although it is possible that this statement needs to be reevaluated in light of the high concentration of VLDLR in the placenta. Instead, lipoprotein lipase hydrolyzes the triglycerides to their component fatty acids making them available for transfer to the fetus.
The source of maternal LC-PUFA Although many tissues are capable of elongating and desaturating a-linolenic and linoleic acids, only the liver is likely to be capable of the export of the resulting LC-PUFA. Other tissues seem likely to retain these products for their own use in membrane building. The liver exports fatty acids in the form of phospholipids and triglycerides packaged as VLDL. Although VLDL metabolism is undoubtably regulated during pregnancy there is relatively little work that would allow evaluation of the hypothesis that the concentration of LC-PUFA's in maternal VLDL is upregulated to respond to the needs of the fetus. It may be simply, as proposed by Lewis (1997) , that the insulin Figure 1 Proposed scheme for lipid¯uxes during pregnancy. In the fed state lipids taken in the diets are absorbed in the maternal intestine as chylomicrons which are delivered to adipose tissue (AT) for storage of lipid and to placenta for hydrolysis of triglyceride and presumed transport of the resultant free fatty acids (FFA) into the fetal circulation. In the fasting state FFA derived from adipose tissue go to the placenta for transport and the liver for VLDL synthesis and possible conversion of essential fatty acids (EFA) into LC-PUFA. In the placenta a fatty acid transporter (FAPB PM ) transfers FFA to the fetal circulation where they may be bound by albumin or alpha-fetoprotein and carried to fetal organs. This process favors LC-PUFA and EFA. VLDL may be transferred across the placenta by the VLDL-receptor (VLDL-R) or utilized by the placenta itself. In the fetal liver EFA may be converted to LC-PUFA for utilization by other organs, particularly the brain.
Adaptation of maternal lipid¯ux to pregnancy MC Neville resistant state of pregnancy with its consequent high fatty acid¯ux to the liver may lead to high rates of VLDL synthesis. The entire matter of the relation between insulin resistance and LC-PUFA requires more investigation. For example, Borkman et al (1993) and colleagues found that the insulin sensitivity of skeletal muscle was negatively correlated with the muscle membrane content of LC-PUFA and suggested a causal relation between the two parameters.
Adaptations of maternal lipid metabolism in pregnancy
That changes in the maternal essential fatty acids and LC-PUFA occur during pregnancy was well-documented in a study of Dutch women by Hornstra and colleagues (Al MDM et al, 1995) . These workers measured the fatty acid composition of plasma phospholipids, presumably in the membrane fractions of plasma lipoproteins, and found that the total phospholipid content of the plasma increased during pregnancy (Figure 2 ) accompanied by an increase in the concentrations of linoleic acid, AA and DHA in the plasma. However, these increases were not as great as the increase in saturated fatty acids and monounsaturated fatty acids, so that the essential fatty acid status [the ratio S(n-3 n-6)aS(n-7 n-9) fatty acids in the plasma phospholipids] declined signi®cantly (Figure 2 ). Other indices that indicate the relative activity of the n-6 and n-3 desaturation pathways also worsened leading these authors to postulate that pregnancy is associated with a maternal de®cit in essential fatty acids. The ®nding that twin and triplet pregnancy (Foreman-van Drongelen et al, 1996) was accompanied by a greater decline in the essential fatty acid status supported this hypothesis. However, more recent studies from the same laboratory in women in other countries (e.g., the English in Figure 2 ; Otto et al, 1997) showed that a good essential fatty acid status at the beginning of pregnancy did not prevent the fall in this index and the worsening of other indices.
The questions then are: (i) Do changes in essential fatty acid status during pregnancy re¯ect maternal adaptation to the needs of the fetus rather than a real nutrient de®cit in the mother? (ii) Might these apparent changes in essential fatty acids and LC-PUFA actually feedback in the liver to stimulate production and export of lipids containing the fatty acids most essential to the fetus? (iii) Does dietary intervention prevent these changes, and, if it does, might the adaptation of the maternal metabolism to the needs of the fetus be abrogated? (iv) Does the insulin resistance of pregnancy contribute to the changing essential fatty acid status during pregnancy? Future experiments designed to answer these questions should provide a sound physiological basis for recommendations for speci®c lipid supplements during pregnancy.
Potential effects of dietary LC-PUFA on maternal adaptation
It has been postulated that the supply of the essential fatty acids, linoleic (18:2, n-6) and a-linolenic (18:3, n-3), that are precursors for the LC-PUFA appear to pose the greatest dietary problem in the pregnant woman. If this is the case then making certain that the diet contains suf®cient quantities of a-linolenic and linoleic acid to provide substrate for LC-PUFA synthesis suf®cient to meet the needs of both the mother and the fetus is the important consideration.
However, another intervention is being proposed, that of directly supplying LC-PUFA, particularly DHA in dietary supplements. One way this can be done is by increasing the amount of ®sh in the diet since ®sh oils are rich in n-3 LC-PUFA. Figure 3 shows the effect of changes in the amount of ®sh ingested on the percentages of AA and DHA in maternal and fetal erythrocytes at term (Sanjurjo et al, 1995) . The n-6an-3 ratio was estimated from the dietary history of ®sh consumption. The greater proportion of both LC-PUFA's in the fetal compared to maternal erythrocytes is evident from this graph as is the enrichment of AA in red cell membranes. An approximately ten-fold increase in the amount of ®sh consumed led to a small increase in DHA in erythrocyte membranes of both mother and fetus and a concomitant decrease in AA. It would be of considerable interest to know whether the amount of ®sh in the diet affected the change in essential fatty acid status associated with pregnancy, e.g. whether maternal adaptation was affected. There is some evidence that increased n-3 fatty Figure 2 Total plasma phospholipid fatty acid (s) and the plasma fatty acid EFA index (n) in Dutch (dm) and English (sn) women as a function of time of gestation. At the right data obtained from maternal venous plasma and fetal cord blood at birth are shown. Drawn from data of Al et al (1995) and Otto et al (1997) . Figure 3 Proportion of LC-PUFA in the red blood cell membranes of maternal blood and fetal cord blood at birth as a function of the dietary ratio of n-6an-3 fatty acids in Spanish women. Note that the LC-PUFA level of both AA and DHA is higher in fetal red blood cells than maternal red blood cells, that AA is much higher than DHA in both and that the presence of higher amounts of ®sh in the diet leads to a small increase in DHA and a reduction in AA in both maternal and fetal red blood cell membranes. Drawn from data of Sanjuro et al (1995) .
Adaptation of maternal lipid¯ux to pregnancy MC Neville S122 acids have salutary effects on the course of pregnancy including decreasing the risks of preterm labor and eclampsia. However, not all studies have shown any effects. More clinical data are essential as well as prospective studies designed to determine the effects of ®sh oil supplementation on maternal adaptation.
Conclusion
The ®nal conclusion at this time must be that we need a much better understanding of the physiological parameters and mechanisms involved in the adaptation of maternal lipid synthesis during pregnancy before recommendations about dietary supplementation of pregnant women with LC-PUFA can be made with con®dence.
